Compare studies and check their requirements with the research team.
This study is completed in France, in the United Kingdom, in Croatia, .... It is testing Transition to the Paliperidone Palmitate 3-Month Formulation for schizophrenia.
Multiple locations, including RijekaThis study is directly about Schizophrenia.
This summary needs review. Please check the official study record and contact the research team for details.
In ChangshaThis study is directly about Schizophrenia.
This study is completed in Portugal. It focuses on schizophrenia.
In PortoThis study is directly about Schizophrenia.
This study is completed in the United States, in the United Kingdom, in Bulgaria, .... It is testing KarXT for schizophrenia.
Multiple locations, including PhoenixThis study is directly about Schizophrenia.
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ASP4345 for schizophrenia.
In GlendaleThis study is directly about Schizophrenia.
This study is completed in China. It is testing KarXT for schizophrenia.
Multiple locations, including HefeiThis study is directly about Schizophrenia.
This study is completed in the United States. It is testing Safety and Efficacy of ASP4345 for schizophrenia.
Multiple locations, including CerritosThis study is directly about Schizophrenia.
This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 for schizophrenia.
Multiple locations, including GlendaleThis study is directly about Schizophrenia.
This study is completed in Rwanda. It is testing treatment of Schizophrenia With Paliperidone Palmitate for schizophrenia.
Multiple locations, including ButareThis study is directly about Schizophrenia.
This study is completed in the United States, in Brazil, and in Mexico. It focuses on schizophrenia.
Multiple locations, including Little RockThis study is directly about Schizophrenia.
This study is completed in the United States, in Bulgaria, in Czechia, .... It focuses on schizophrenia.
Multiple locations, including Garden GroveThis study is directly about Schizophrenia.
This study is completed in the United States. It is testing Iloperidone Long-acting Injection (LAI) for schizophrenia.
Multiple locations, including Garden GroveThis study is directly about Schizophrenia.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.